Table 3.
Cox’s proportional hazard models for bone metastasis and other known prognostics factors.
| PFS Overall | PFS Immunotherapy | PFS Targeted Therapy | |||||
|---|---|---|---|---|---|---|---|
| HR | P | HR | P | HR | P | ||
| Univariable | Bone Metastasis | 1.30 | 0.009 | 1.01 | 0.933 | 1.41 | 0.129 |
| Multivariable | Performance Status | 1.34 | 0.001 | 1.38 | 0.009 | 1.04 | 0.825 |
| Number of Metastatic Sites | 1.00 | 0.906 | 0.97 | 0.306 | 1.08 | 0.094 | |
| High LDH | 1.74 | <0.001 | 1.52 | 0.018 | 1.49 | 0.179 | |
| OS Overall | OS Immunotherapy | OS Targeted Therapy | |||||
| HR | P | HR | P | HR | P | ||
| Univariable | Bone Metastasis | 1.81 | <0.001 | 1.34 | 0.067 | 1.77 | 0.031 |
| Multivariable | Bone Metastasis | 1.38 | 0.047 | 1.11 | 0.611 | 1.96 | 0.048 |
| Performance Status | 1.82 | <0.001 | 1.98 | <0.001 | 1.38 | 0.060 | |
| Number of Metastatic Sites | 1.06 | 0.017 | 1.04 | 0.236 | 1.09 | 0.091 | |
| High LDH | 1.62 | 0.003 | 1.55 | 0.041 | 1.33 | 0.354 | |